FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1664777781> ?p ?o ?g. }

• W1664777781 abstract "Background Vitamin B is frequently used for treating peripheral neuropathy but its efficacy is not clear. Objectives The objective of this review was to assess the effects of vitamin B for treating generalised peripheral neuropathy. Search methods We searched the Cochrane Neuromuscular Disease Group Trials Register (searched August 2005), MEDLINE (January 1966 to September 2005), EMBASE (January 1980 to September 2005), Philippine databases (searched September 2005) and reference lists of articles. We also contacted manufacturers and researchers in the field. Selection criteria Randomised and quasi‐randomised trials where vitamin B was compared with placebo or another treatment in generalised peripheral neuropathy. Data collection and analysis Two authors independently assessed trial quality and extracted data. We contacted study authors for additional information. Main results Thirteen studies involving 741 participants with alcoholic or diabetic neuropathy were included. In the comparison of vitamin B with placebo, two small trials showed no significant short‐term benefit in pain intensity while one of the trials showed a small significant benefit in vibration detection from oral benfotiamine, a derivative of thiamine. In the larger of two trials comparing different doses of vitamin B complex, there was some evidence that higher doses resulted in a significant short‐term reduction in pain and improvement in paraesthesiae, in a composite outcome combining pain, temperature and vibration, and in a composite outcome combining pain, numbness and paraesthesiae. There was some evidence that vitamin B is less efficacious than alpha‐lipoic acid, cilostazol or cytidine triphosphate in the short‐term improvement of clinical and nerve conduction study outcomes but the trials were small. There were few minor adverse effects reported. Authors' conclusions There are only limited data in randomised trials testing the efficacy of vitamin B for treating peripheral neuropathy and the evidence is insufficient to determine whether vitamin B is beneficial or harmful. One small trial in alcoholic peripheral neuropathy reported slightly greater improvement in vibration perception threshold with oral benfotiamine for eight weeks than placebo. In another small study, a higher dose of oral vitamin B complex for four weeks was more efficacious than a lower dose in reducing symptoms and signs. Vitamin B administered by various routes for two to eight weeks was less efficacious than alpha‐lipoic acid, cilostazol or cytidine triphosphate in short‐term improvement of clinical and nerve conduction study outcomes. Vitamin B is generally well‐tolerated." @default.
• W1664777781 created "2016-06-24" @default.
• W1664777781 creator A5008606851 @default.
• W1664777781 creator A5014537987 @default.
• W1664777781 creator A5036839691 @default.
• W1664777781 creator A5039399502 @default.
• W1664777781 creator A5043310667 @default.
• W1664777781 creator A5053943897 @default.
• W1664777781 creator A5032405467 @default.
• W1664777781 creator A5054147564 @default.
• W1664777781 creator A5079252984 @default.
• W1664777781 date "2008-07-16" @default.
• W1664777781 modified "2023-10-14" @default.
• W1664777781 title "Vitamin B for treating peripheral neuropathy" @default.
• W1664777781 cites W1970923106 @default.
• W1664777781 cites W1981921738 @default.
• W1664777781 cites W1983997432 @default.
• W1664777781 cites W1986309799 @default.
• W1664777781 cites W1991993073 @default.
• W1664777781 cites W1994033499 @default.
• W1664777781 cites W1998999722 @default.
• W1664777781 cites W2001024287 @default.
• W1664777781 cites W2010111144 @default.
• W1664777781 cites W2017861431 @default.
• W1664777781 cites W2018500673 @default.
• W1664777781 cites W2034636991 @default.
• W1664777781 cites W2035178485 @default.
• W1664777781 cites W2040247587 @default.
• W1664777781 cites W2041804815 @default.
• W1664777781 cites W2042862034 @default.
• W1664777781 cites W2046260688 @default.
• W1664777781 cites W2055429033 @default.
• W1664777781 cites W2055876879 @default.
• W1664777781 cites W2068457658 @default.
• W1664777781 cites W2078251903 @default.
• W1664777781 cites W2108982296 @default.
• W1664777781 cites W2135932738 @default.
• W1664777781 cites W2141017563 @default.
• W1664777781 cites W2158277897 @default.
• W1664777781 cites W2163205990 @default.
• W1664777781 cites W2163677744 @default.
• W1664777781 cites W2167408146 @default.
• W1664777781 cites W2245108456 @default.
• W1664777781 cites W2403317786 @default.
• W1664777781 cites W2415139703 @default.
• W1664777781 cites W2418694951 @default.
• W1664777781 cites W28249279 @default.
• W1664777781 cites W4213185638 @default.
• W1664777781 cites W59993581 @default.
• W1664777781 doi "https://doi.org/10.1002/14651858.cd004573.pub3" @default.
• W1664777781 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18646107" @default.
• W1664777781 hasPublicationYear "2008" @default.
• W1664777781 type Work @default.
• W1664777781 sameAs 1664777781 @default.
• W1664777781 citedByCount "65" @default.
• W1664777781 countsByYear W16647777812012 @default.
• W1664777781 countsByYear W16647777812013 @default.
• W1664777781 countsByYear W16647777812014 @default.
• W1664777781 countsByYear W16647777812015 @default.
• W1664777781 countsByYear W16647777812016 @default.
• W1664777781 countsByYear W16647777812017 @default.
• W1664777781 countsByYear W16647777812018 @default.
• W1664777781 countsByYear W16647777812019 @default.
• W1664777781 countsByYear W16647777812020 @default.
• W1664777781 countsByYear W16647777812021 @default.
• W1664777781 countsByYear W16647777812022 @default.
• W1664777781 countsByYear W16647777812023 @default.
• W1664777781 crossrefType "journal-article" @default.
• W1664777781 hasAuthorship W1664777781A5008606851 @default.
• W1664777781 hasAuthorship W1664777781A5014537987 @default.
• W1664777781 hasAuthorship W1664777781A5032405467 @default.
• W1664777781 hasAuthorship W1664777781A5036839691 @default.
• W1664777781 hasAuthorship W1664777781A5039399502 @default.
• W1664777781 hasAuthorship W1664777781A5043310667 @default.
• W1664777781 hasAuthorship W1664777781A5053943897 @default.
• W1664777781 hasAuthorship W1664777781A5054147564 @default.
• W1664777781 hasAuthorship W1664777781A5079252984 @default.
• W1664777781 hasConcept C126322002 @default.
• W1664777781 hasConcept C134018914 @default.
• W1664777781 hasConcept C142724271 @default.
• W1664777781 hasConcept C204787440 @default.
• W1664777781 hasConcept C27081682 @default.
• W1664777781 hasConcept C2776940978 @default.
• W1664777781 hasConcept C2779901536 @default.
• W1664777781 hasConcept C535046627 @default.
• W1664777781 hasConcept C555293320 @default.
• W1664777781 hasConcept C71924100 @default.
• W1664777781 hasConceptScore W1664777781C126322002 @default.
• W1664777781 hasConceptScore W1664777781C134018914 @default.
• W1664777781 hasConceptScore W1664777781C142724271 @default.
• W1664777781 hasConceptScore W1664777781C204787440 @default.
• W1664777781 hasConceptScore W1664777781C27081682 @default.
• W1664777781 hasConceptScore W1664777781C2776940978 @default.
• W1664777781 hasConceptScore W1664777781C2779901536 @default.
• W1664777781 hasConceptScore W1664777781C535046627 @default.
• W1664777781 hasConceptScore W1664777781C555293320 @default.
• W1664777781 hasConceptScore W1664777781C71924100 @default.
• W1664777781 hasLocation W16647777811 @default.
• W1664777781 hasLocation W16647777812 @default.
• W1664777781 hasOpenAccess W1664777781 @default.

• next